Research

The t:slim has become a popular choice with artificial pancreas researchers. Its “hormone agnostic” approach might be part of the reason why.

The Insulin Nation T1D Tech Roundup for June 2014

Two Toronto Blue Jays pitchers with T1 wear pumps on the mound.

A new pump user gets pushed into an infusion set that doesn’t work for her. Only later does she learn she has options.

Teens with artificial pancreas systems, hip glucometers, once-a-year glucometers and more!

Learn about all the latest tech advances to make life easier for people with diabetes.

An endocrinologist shares the limits and pitfalls of pump therapy, and how it can’t beat a cure.

A road trip almost ends in disaster for Andy Holder if not for the help of his pump manufacturer.

Advances in sock technology hold the promise for better foot-care, and fewer amputations, for people with diabetes.

Google says it is developing a contact lens to measure glucose. Will it work?

The company warns of insulin leakage.

Western New England University researchers announce they have created a device that detects acetone levels on the breath of people with diabetes.

The company warns that some of its test strips could give inaccurately low BG readings.

Novo Nordisk gains FDA approval for two automated dose pens.

iHealth touts its new BGM as a sleek companion to smartphone technology.

An Australian study finds that T1 users on smart pumps enjoy four times fewer bouts of hypoglycemia.

Feds warn Medtronic about inferior manufacturing practices for the pump.

Can Tandem's User-Friendly t:slim Make Pumping Insulin The Therapy of Choice?

The rumored end to Bayer Diabetes’ production of A1cNow speaks volumes about the new math of the business of diabetes care.

Electrical nerve stimulation offers hope of pain relief for people who suffer from diabetic peripheral neuropathy. Sensus, a new FDA-approved product, aims to manage pain by stimulating healthy nerve function.